Literature DB >> 26045779

Involvement of Notch1/Hes signaling pathway in ankylosing spondylitis.

Wei Xu1, Chao-Ge Liang1, Yi-Fan Li1, Yun-Han Ji1, Wen-Jun Qiu1, Xian-Zhong Tang1.   

Abstract

We aimed to investigate the role of Notch1/Hes signaling pathway in the pathogenesis of abnormal ossification of hip ligament in patients with ankylosing spondylitis (AS). 22 AS patients scheduled for artificial hip arthroplasty were randomly chosen as AS group. As controls, we used 4 patients diagnosed with transcervical fracture who underwent hip replacement surgery. Notch1 and Hes mRNA expressions were detected by real-time fluorescent quantitative polymerase chain reaction (RFQ-PCR). Immunohistochemistry (IHC) was used to detect Notch1 and Hes protein expression. Correlation analyses of Notch-l and Hes with AS-related clinical factors were conducted with spearman's correlation analysis and partial correlation analysis. RFQ-PCR results showed significant differences in Notch1 and Hes mRNA expressions between AS group and the control group (all P<0.05). IHC analysis further indicated positive nuclear signals of Notch1 and Hes protein, indicating functional activation of the Notch1 and Hes pathways. Semi-quantitative IHC showed a higher Notch1 and Hes expression levels in AS group compared to the control group (all P<0.05). Correlation analysis suggested that Hes protein expression was positively associated with the clinical course of the disease in AS patients. In conclusion, Notch1 and Hes overexpression was clearly detected in hip joint ligaments of AS patients, Hes protein expression was associated with the clinical course of AS. Taken together, we suggest that signaling pathways mediated by Notch1-Hes may contribute to ligament ossification of hip joints in AS patients.

Entities:  

Keywords:  Notch1; ankylosing spondylitis; clinical course; hairy enhancer of split; hip joint ligament; mRNA expressions; protein expressions; signaling pathway

Mesh:

Substances:

Year:  2015        PMID: 26045779      PMCID: PMC4440088     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  37 in total

1.  Effects of tumor necrosis factor-alpha on sexual activity of male patients with ankylosing spondylitis.

Authors:  Xin Dong; Yi Zheng; Tian-Yan Shi; Hong-Yan Liu
Journal:  Clin Rheumatol       Date:  2014-07-27       Impact factor: 2.980

2.  The involvement of Notch signaling in melanoma vasculogenic mimicry.

Authors:  Amalia Vartanian; Galina Gatsina; Irina Grigorieva; Elico Solomko; Vladislav Dombrovsky; Anatoly Baryshnikov; Eugenia Stepanova
Journal:  Clin Exp Med       Date:  2012-05-25       Impact factor: 3.984

3.  The association between tumor necrosis factor alpha promoter polymorphisms and ankylosing spondylitis: a meta-analysis.

Authors:  Bo Ma; Bing Yang; Hainiu Guo; Yihong Wang; Dayi Zhang; Yuan Zhang; Zhengquan Xiao
Journal:  Hum Immunol       Date:  2013-07-02       Impact factor: 2.850

4.  A simplified version of Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with ankylosing spondylitis.

Authors:  Fernando A Sommerfleck; Emilce E Schneeberger; Emilio E Buschiazzo; José A Maldonado Cocco; Gustavo Citera
Journal:  Clin Rheumatol       Date:  2012-08-16       Impact factor: 2.980

5.  The efficacy and safety of Jitongning Capsule () in patients with ankylosing spondylitis.

Authors:  Yan-Yan Wang; Hui Lu; Zheng Zhao; Feng Huang
Journal:  Chin J Integr Med       Date:  2013-01-31       Impact factor: 1.978

6.  Heterogeneity in signaling pathways of gastroenteropancreatic neuroendocrine tumors: a critical look at notch signaling pathway.

Authors:  He Wang; Yili Chen; Carlos Fernandez-Del Castillo; Omer Yilmaz; Vikram Deshpande
Journal:  Mod Pathol       Date:  2012-08-24       Impact factor: 7.842

7.  Investigation of deregulated genes of Notch signaling pathway in human T cell acute lymphoblastic leukemia cell lines and clinical samples.

Authors:  Mahdi Paryan; Samira Mohammadi-Yeganeh; Siamak Mirab Samiee; Masoud Soleimani; Ehsan Arefian; Keyhan Azadmanesh; Behzad Poopak; Ehsan Mostafavi; Morteza Karimipoor; Reza Mahdian
Journal:  Mol Biol Rep       Date:  2013-08-29       Impact factor: 2.316

Review 8.  Genetics of ankylosing spondylitis.

Authors:  Philip C Robinson; Matthew A Brown
Journal:  Mol Immunol       Date:  2013-07-31       Impact factor: 4.407

9.  MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma.

Authors:  Kyu Yeoun Won; Youn Wha Kim; Hyun-Sook Kim; Seung Kwan Lee; Woon-Won Jung; Yong-Koo Park
Journal:  Hum Pathol       Date:  2013-04-08       Impact factor: 3.466

10.  Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis.

Authors:  Ali Taylan; Ismail Sari; Baris Akinci; Safak Bilge; Didem Kozaci; Servet Akar; Ayfer Colak; Hulya Yalcin; Necati Gunay; Nurullah Akkoc
Journal:  BMC Musculoskelet Disord       Date:  2012-10-02       Impact factor: 2.362

View more
  4 in total

Review 1.  Conserved signaling pathways underlying heterotopic ossification.

Authors:  Chen Kan; Lijun Chen; Yangyang Hu; Na Ding; Haimei Lu; Yuyun Li; John A Kessler; Lixin Kan
Journal:  Bone       Date:  2017-04-25       Impact factor: 4.398

2.  Gene Expression Analysis before and after Treatment with Adalimumab in Patients with Ankylosing Spondylitis Identifies Molecular Pathways Associated with Response to Therapy.

Authors:  Marzia Dolcino; Elisa Tinazzi; Andrea Pelosi; Giuseppe Patuzzo; Francesca Moretta; Claudio Lunardi; Antonio Puccetti
Journal:  Genes (Basel)       Date:  2017-04-24       Impact factor: 4.096

3.  Expression and oncogenic properties of membranous Notch1 in oral leukoplakia and oral squamous cell carcinoma.

Authors:  Xu Ding; Yang Zheng; Zhao Wang; Wei Zhang; Yibo Dong; Wantao Chen; Jiang Li; Weiming Chu; Wei Zhang; Yi Zhong; Li Mao; Xiaomeng Song; Yunong Wu
Journal:  Oncol Rep       Date:  2018-03-27       Impact factor: 3.906

4.  MicroRNA‑204‑5p inhibits the osteogenic differentiation of ankylosing spondylitis fibroblasts by regulating the Notch2 signaling pathway.

Authors:  Jianjun Zhao; Yanyan Zhang; Bo Liu
Journal:  Mol Med Rep       Date:  2020-07-06       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.